High-grade Serous Ovarian Carcinoma (HGSOC) Active Not Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: B. High Grade Serous Ovarian Cancer / Ovarian High Grade Serous Carcinoma / High-grade Serous Ovarian Cancer / High-grade Serous Ovarian Carcinoma / High Grade Serous Ovarian Carcinoma / High Grade Serous Ovarian Cancer / High Grade Ovarian Serous / High Grade Serous Ovarian

IndicationStatusPhase
DBCOND0140551 (High-grade Serous Ovarian Carcinoma (HGSOC))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05446870Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002)Treatment